Combo COVID/Flu Vax Results In “Strong Immunity”

June 10, 2024 Medicine, Science

Moderna’s combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to getting the flu and COVID shots separately, according to the company’s results from a late-stage clinical trial.

There are still multiple steps required before the shot would become available. Moderna would need to apply to the FDA for approval, which may require input from the FDA’s independent panel of experts. If authorized or approved, the shot would also need to be greenlit by the CDC before becoming available.

The clinical trial was done in 8,000 adults. Half of those adults were 65 years and older and the other half were between the ages of 50 and 64. Older adults are especially at risk for severe illness from respiratory illnesses including hospitalization and death.

Read the full article.

Main goal of a Phase 3 test of @moderna_tx‘s combination #vaccine for #flu & #COVID19 is showing non-inferiority to individual #vaccines currently available. The combo $MRNA combo vax did even better, achieving higher immune responses vs. comparator shots.https://t.co/bJPZWskzJ5

— Frank Vinluan (@frankvinluan) June 10, 2024